Moreover, as grade 4 neutropenia and febrile neutropenia represented the only significant toxicities in our study, the 12% incidence of the latter appears rather low and compares favourably to that of single agent docetaxel at 100 mg m−2 with G-CSF support. The gene discussed is CSF3; the disease is neutropenia.